Patents by Inventor Pierrick RIVAL

Pierrick RIVAL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL RNA COMPOSITIONS AND METHODS FOR INHIBITING ANGPTL3
    Publication number: 20230383294
    Abstract: The present disclosure relates to dsRNAs targeting ANGPTL3, methods of inhibiting ANGPTL3 gene expression, and methods of treating one or more conditions associated with ANGPTL3 gene expression.
    Type: Application
    Filed: October 15, 2021
    Publication date: November 30, 2023
    Inventors: Bodo BRUNNER, Mike HELMS, Armin HOFMEISTER, Kerstin JAHN-HOFMANN, Christiane METZ-WEIDMANN, Sabine SCHEIDLER, Pierrick RIVAL
  • COMPOSITIONS AND METHODS FOR INHIBITING PCSK9
    Publication number: 20220290156
    Abstract: Provided herein, inter alia, are dsRNA compositions targeting PCSK9, methods of inhibiting PCSK9 gene expression, and methods of treating one or more diseases associated with PCSK9 gene expression.
    Type: Application
    Filed: August 27, 2020
    Publication date: September 15, 2022
    Applicant: SANOFI
    Inventors: Bodo BRUNNER, Kerstin JAHN-HOFMANN, Sabine SCHEIDLER, Pierrick RIVAL
  • NOVEL RNA COMPOSITIONS AND METHODS FOR INHIBITING ANGPTL8
    Publication number: 20220025367
    Abstract: The present disclosure relates to dsRNAs targeting ANGPTL8, methods of inhibiting ANGPTL8 gene expression, and methods of treating one or more conditions associated with ANGPTL8 gene expression.
    Type: Application
    Filed: November 22, 2019
    Publication date: January 27, 2022
    Applicant: Sanofi
    Inventors: Bodo BRUNNER, Mike HELMS, Armin HOFMEISTER, Kerstin JAHN-HOFMANN, Christiane METZ-WEIDMANN, Sabine SCHEIDLER, Pierrick RIVAL